CRNX - Crinetics Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRNX is currently covered by 10 analysts with an average price target of $62.56. This is a potential upside of $27.91 (80.55%) from yesterday's end of day stock price of $34.65.

Crinetics Pharmaceuticals's activity chart (see below) currently has 37 price targets and 77 ratings on display. The stock rating distribution of CRNX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.18% with an average time for these price targets to be met of 438.17 days.

Highest price target for CRNX is $90, Lowest price target is $81, average price target is $71.7.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 11-Aug-2025. First documented stock forecast 13-Aug-2018.

Currently out of the existing stock ratings of CRNX, 50 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$86

$55.01 (177.51%)

$91

23 days ago
(11-Aug-2025)

9/17 (52.94%)

$58.62 (214.10%)

394

Buy

$81

$50.01 (161.37%)

$81

2 months 7 days ago
(27-Jun-2025)

14/18 (77.78%)

$51.04 (170.36%)

265

Buy

$90

$59.01 (190.42%)

$65

11 months 18 days ago
(16-Sep-2024)

3/6 (50%)

$36.06 (66.85%)

131

Buy

$73

$42.01 (135.56%)

$74

1 years 25 days ago
(09-Aug-2024)

5/7 (71.43%)

$25.36 (53.23%)

146

Buy

$54

$23.01 (74.25%)

$47

1 years 1 months 25 days ago
(09-Jul-2024)

9/9 (100%)

$5.77 (11.96%)

183

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRNX (Crinetics Pharmaceuticals) average time for price targets to be met?

On average it took 438.17 days on average for the stock forecasts to be realized with a an average price target met ratio 65.18

Which analyst has the current highest performing score on CRNX (Crinetics Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on CRNX (Crinetics Pharmaceuticals)?

Charles Duncan works at CANTOR FITZGERALD and has 12 price targets and 8 ratings on CRNX

Which analyst is the currently most bullish on CRNX (Crinetics Pharmaceuticals)?

Yasmeen Rahimi with highest potential upside - $66.01

Which analyst is the currently most reserved on CRNX (Crinetics Pharmaceuticals)?

Tyler Van Buren with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?